Abstract
Background
Data on impact of financial hardship on coronary artery disease (CAD) remain incomplete.
Methods
Consecutive subjects referred for clinical rest/stress cardiac positron emission tomography (PET) were enrolled. Financial hardship is defined as patients’ inability to pay for their out-of-pocket expense for cardiac PET. Abnormal cardiac PET is defined as at least moderate relative perfusion defects at stress involving > 10% of the left ventricle or global coronary flow reserve ≤ 2.0. Patients were followed for major adverse cardiovascular event (MACE) comprised of all-cause mortality, non-fatal myocardial infarction, and late coronary revascularization.
Results
We analyzed a total of 4173 patients with mean age 65.6 ± 11.3 years, 72.2% men, and 93.6% reported as having medical insurance. Of these, 504 (12.1%) patients had financial hardship. On multivariable analysis, financial hardship associated with abnormal cardiac PET (odds ratio 1.377, p = 0.004) and MACE (hazard ratio 1.432, p = 0.010) and its association with MACE was mostly through direct effect with small proportion mediated by abnormal cardiac PET or known CAD.
Conclusion
Among patients referred for cardiac rest/stress PET, financial hardship independently associates with myocardial perfusion abnormalities and MACE; however, its effect on MACE is largely not mediated by abnormal myocardial perfusion or known CAD suggesting distinct impact of financial hardship beyond traditional risk factors and CAD that deserves attention and intervention to effectively reduced adverse outcomes. Having medical insurance does not consistently protect from financial hardship and a more preventive-oriented restructuring may provide better outcomes at lower cost.
Similar content being viewed by others
Abbreviations
- PET:
-
Positron emission tomography
- DCI:
-
Distress Community Index
- CT:
-
Computed tomography
- CFR:
-
Coronary flow reserve
- CAD:
-
Coronary artery disease
- OR:
-
Odds ratio
- CI:
-
Confidence interval
- HR:
-
Hazard ratio
References
Virani SS, Alonso A, Aparicio HJ, et al. Heart disease and stroke statistics-2021 update: A report from the American Heart Association. Circulation 2021;143:e254‐743. https://doi.org/10.1161/CIR.0000000000000950.
Schultz WM, Kelli HM, Lisko JC, et al. Socioeconomic status and cardiovascular outcomes: Challenges and interventions. Circulation 2018;137:2166‐78. https://doi.org/10.1161/CIRCULATIONAHA.117.029652.
Stringhini S, Carmeli C, Jokela M, et al. Socioeconomic status and the 25 × 25 risk factors as determinants of premature mortality: A multicohort study and meta-analysis of 1·7 million men and women. Lancet 2017;389:1229‐37. https://doi.org/10.1016/S0140-6736(16)32380-7.
Kucharska-Newton AM, Harald K, Rosamond WD, Rose KM, Rea TD, Salomaa V. Socioeconomic indicators and the risk of acute coronary heart disease events: comparison of population-based data from the United States and Finland. Ann Epidemiol 2011;21:572‐9. https://doi.org/10.1016/j.annepidem.2011.04.006.
Stirbu I, Looman C, Nijhof GJ, Reulings PG, Mackenbach JP. Income inequalities in case death of ischaemic heart disease in the Netherlands: A national record-linked study. J Epidemiol Community Health 2012;66:1159‐66. https://doi.org/10.1136/jech-2011-200924.
Ohm J, Skoglund PH, Discacciati A, et al. Socioeconomic status predicts second cardiovascular event in 29,226 survivors of a first myocardial infarction. Eur J Prev Cardiol 2018;25:985‐93. https://doi.org/10.1177/2047487318766646.
Mehaffey JH, Hawkins RB, Charles EJ, et al. Distressed communities are associated with worse outcomes after coronary artery bypass surgery. J Thorac Cardiovasc Surg 2020;160:425-432.e9. https://doi.org/10.1016/j.jtcvs.2019.06.104.
Hamad R, Penko J, Kazi DS, et al. Association of low socioeconomic status with premature coronary heart disease in US adults. JAMA Cardiol 2020;5:899‐908. https://doi.org/10.1001/jamacardio.2020.1458.
Conklin AI, Forouhi NG, Suhrcke M, Surtees P, Wareham NJ, Monsivais P. Socioeconomic status, financial hardship and measured obesity in older adults: A cross-sectional study of the EPIC-Norfolk cohort. BMC Public Health 2013;13:1039. https://doi.org/10.1186/1471-2458-13-1039.
Grandhi GR, Valero-Elizondo J, Mszar R, et al. Association of cardiovascular risk factor profile and financial hardship from medical bills among non-elderly adults in the United States. Am J Prev Cardiol 2020;2:100034. https://doi.org/10.1016/j.ajpc.2020.100034.
Kitkungvan D, Lai D, Zhu H, et al. Optimal adenosine stress for maximum stress perfusion, coronary flow reserve, and pixel distribution of coronary flow capacity by Kolmogorov-Smirnov analysis. Circulation. 2017. https://doi.org/10.1161/CIRCIMAGING.116.005650.
Kitkungvan D, Johnson NP, Roby AE, Patel MB, Kirkeeide R, Gould KL. Routine clinical quantitative rest stress myocardial perfusion for managing coronary artery disease: clinical relevance of test-retest variability. JACC. 2017. https://doi.org/10.1016/j.jcmg.2016.09.019.
Kitkungvan D, Bui L, Johnson NP, et al. Quantitative myocardial perfusion positron emission tomography and caffeine revisited with new insights on major adverse cardiovascular events and coronary flow capacity. Eur Heart J Cardiovasc Imaging 2019;20:751‐62. https://doi.org/10.1093/ehjci/jez080.
Bateman TM, Heller GV, Beanlands R, et al. Practical guide for interpreting and reporting cardiac PET measurements of myocardial blood flow: an information statement from the American Society of Nuclear Cardiology, and the Society of Nuclear Medicine and Molecular Imaging. J Nucl Med 2021;62:1599‐615. https://doi.org/10.2967/jnumed.121.261989.
Discacciati A, Bellavia A, Lee JJ, Mazumdar M, Valeri L. Med4way: a Stata command to investigate mediating and interactive mechanisms using the four-way effect decomposition. Int J Epidemiol. 2018. https://doi.org/10.1093/ije/dyy236.
Moran KE, Ommerborn MJ, Blackshear CT, Sims M, Clark CR. Financial stress and risk of coronary heart disease in the Jackson heart study. Am J Prev Med 2019;56:224‐31. https://doi.org/10.1016/j.amepre.2018.09.022.
Valero-Elizondo J, Khera R, Saxena A, et al. Financial hardship from medical bills among nonelderly U.S. adults with atherosclerotic cardiovascular disease. J Am Coll Cardiol. 2019;73:727‐32. https://doi.org/10.1016/j.jacc.2018.12.004.
Lauer MS, Blackstone EH, Young JB, Topol EJ. Cause of death in clinical research: time for a reassessment? J Am Coll Cardiol 1999;34:618‐20. https://doi.org/10.1016/s0735-1097(99)00250-8.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
Danai Kitkungvan, Nils P. Johnson, Linh Bui, Monica B. Patel, Amanda E. Roby, Mary Haynie, Richard Kirkeeide, Susan Hood, and K. Lance Gould declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The authors have also provided an audio summary of the article, which is available to download as ESM, or to listen to via the JNC/ASNC Podcast.
The authors of this article have provided a PowerPoint file, available for download at SpringerLink, which summarises the contents of the paper and is free for re-use at meetings and presentations. Search for the article DOI on SpringerLink.com.
Funding
Research supported by internal funds of the Weatherhead PET Center No authors have a relationship with industry related to this manuscript. NPJ received internal funding from Weatherhead PET Center for Preventing and Reversing Atherosclerosis and research support from St. Jude Medical (for NCT02184117) and Volcano/Philips Corporation (for NCT02328820). KLG received internal funding from the Weatherhead PET Center and is the applicant for 510(k) FDA cleared HeartSee K171303 PET software. To avoid any conflict of interest, KLG assigned any royalties arising from PET software to UT for research or student scholarships.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Kitkungvan, D., Johnson, N.P., Bui, L. et al. Does financial hardship associate with abnormal quantitative myocardial perfusion and major adverse cardiovascular event?. J. Nucl. Cardiol. 30, 1528–1539 (2023). https://doi.org/10.1007/s12350-022-03184-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12350-022-03184-1